LIDOCAINE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of one package of LIDOCAINE HYDROCHLORIDE INJECTION, identified by NSN 6505015332656, at a unit price of $46.86, resulting in a total contract value of $46.86. The delivery is scheduled for July 15, 2026, with FOB destination terms, meaning the contractor assumes all costs and risks of transportation to the final delivery point: USS ILLINOIS SSN-786, FPO AP 96694. Inspection and acceptance occur at the destination by the government, with zero tolerance for quantity variance. The payment office is located in Columbus, Ohio, and invoices must comply with DFARS 252.232-7003, indicating electronic submission through the Wide Area WorkFlow system. Contract administration is managed by Lisa Quinn as the contracting officer, with Jayne Do as the administrative contact. The contract was issued as a single-line-item delivery under an IDIQ vehicle, with no options, clauses, special requirements, or socioeconomic certifications explicitly included in the documentation. Packaging, labeling, barcoding, and MIL-STD requirements are not detailed, though DLAD PROC NOTES C19 and C20 are referenced for transportation. No attachments, representations, or evaluation factors are listed, suggesting this is a streamlined, low-value fulfillment against an existing agreement with minimal administrative overhead beyond payment and delivery compliance.